This article was first published 23 years ago
Home  » Business » Ranbaxy gets USFDA nod for generic Serzone

Ranbaxy gets USFDA nod for generic Serzone

April 28, 2003 14:29 IST
google preferred source
The United States Food and Drugs Administration has granted Ranbaxy Laboratories a tentative approval to market a generic form of Bristol-Myers' anti-depressant
v_1">
Serzone, US FDA's web site said.

More From Rediff

'It Isn't About Noel Tata, It Isn't Even About Chandra'

'It Isn't About Noel Tata, It Isn't Even About Chandra'
'This ₹2,000 MDR Limit Is Bogus'

'This ₹2,000 MDR Limit Is Bogus'

Tata's Problem Is India's Problem

Tata's Problem Is India's Problem

Web Stories

Lava Bold N4 Pro 5G Arrives September 26

Lava Bold N4 Pro 5G Arrives September 26
OnePlus 13s 16 GB RAM Variant Arrives

OnePlus 13s 16 GB RAM Variant Arrives
World's Best 7 Airlines Of 2026

World's Best 7 Airlines Of 2026

Moneywiz Live!